Global mRNA Vaccines and Therapeutics Market (2021 to 2025) – by Application, mRNA Type and Country Data – ResearchAndMarkets.com

Global mRNA Vaccines and Therapeutics Market (2021 to 2025) – by Application, mRNA Type and Country Data – ResearchAndMarkets.com




Global mRNA Vaccines and Therapeutics Market (2021 to 2025) – by Application, mRNA Type and Country Data – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global mRNA Vaccines and Therapeutics Market: Focus on Application, mRNA Type, Country Data (13 Countries), and Competitive Landscape – Analysis and Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.

The publisher’s healthcare experts have found the mRNA vaccines and therapeutics market to be one of the most rapidly evolving and dynamic markets, and the global market for mRNA vaccines and therapeutics for COVID-19 vaccines is predicted to grow at a CAGR of -13.50% over the forecast period of 2021-2025.

Moreover, the global market for mRNA vaccines and therapeutics for non-COVID-19 vaccines is predicted to grow at a CAGR of 95.49% over the forecast period of 2026-2031. The overall global mRNA vaccines and therapeutics market is driven by certain factors, which include growing cases of COVID-19 globally, a favorable regulatory environment, and significant external funding for the development of mRNA-based COVID-19 vaccines.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global mRNA vaccines and therapeutics market?
  • What are the key development strategies being implemented by the major players in order to sustain in the competitive market?
  • What are the key regulatory implications in developed and developing regions for the global mRNA vaccines and therapeutics market?
  • How is each segment of the market expected to grow during the forecast period, 2021-2031?
  • Who are the leading players with significant offerings to the global mRNA vaccines and therapeutics market, and what is the expected market dominance for each of these leading players?
  • What are the adoption trends for mRNA vaccines and therapeutics in established economies and emerging economies across the world?
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • What are the current clinical unmet needs that are being faced in the global mRNA vaccines and therapeutics market?
  • What are the dynamics of various application areas and countries, which are impacting the global mRNA vaccines and therapeutics market?
  • What are the new market opportunities that are influencing the growth of the global mRNA vaccines and therapeutics market?
  • How is each segment of the market expected to grow during the forecast period from 2021 to 2031? Following are the segment types
  • What are the unmet needs currently existing in the global mRNA vaccines and therapeutics market?

Market Dynamics

Drivers

  • Growing Cases of COVID-19 Globally
  • Favorable Regulatory Environment
  • Significant External Funding for the Development of mRNA-Based COVID-19 Vaccines

Restraints

  • Logistical Challenges Associated with mRNA-Based COVID-19 Vaccines
  • High Price Associated with mRNA-Based COVID-19 Vaccines

Opportunities

  • Growing Emphasis on Research and Development for Non-COVID-19 Applications

Companies Mentioned

  • Arcturus Therapeutics Holdings Inc.
  • BioNTech SE
  • CureVac N.V.
  • Daiichi Sankyo Company, Limited.
  • ethris GmbH
  • Gennova Biopharmaceuticals Ltd
  • GlaxoSmithKline plc
  • Moderna, Inc.
  • Pantherna Therapeutics GmbH
  • Providence Therapeutics
  • Silence Therapeutics
  • Translate Bio
  • VERSAMEB AG
  • Verve Therapeutics, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/mdxf7k

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900